BRPI0910991A2 - Substituted piperidines as therapeutic compounds - Google Patents

Substituted piperidines as therapeutic compounds

Info

Publication number
BRPI0910991A2
BRPI0910991A2 BRPI0910991A BRPI0910991A BRPI0910991A2 BR PI0910991 A2 BRPI0910991 A2 BR PI0910991A2 BR PI0910991 A BRPI0910991 A BR PI0910991A BR PI0910991 A BRPI0910991 A BR PI0910991A BR PI0910991 A2 BRPI0910991 A2 BR PI0910991A2
Authority
BR
Brazil
Prior art keywords
therapeutic compounds
substituted piperidines
piperidines
substituted
therapeutic
Prior art date
Application number
BRPI0910991A
Other languages
Portuguese (pt)
Inventor
Aleksandar Stojanovic
Dirk Behnke
Peter Herold
Robert Mah
Stefan Stutz
Stjepan Jelakovic
Vincenzo Tschinke
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0910991A2 publication Critical patent/BRPI0910991A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0910991A 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds BRPI0910991A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153929 2008-04-02
PCT/EP2009/053898 WO2009121914A1 (en) 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds

Publications (1)

Publication Number Publication Date
BRPI0910991A2 true BRPI0910991A2 (en) 2016-01-19

Family

ID=40627638

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910991A BRPI0910991A2 (en) 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds

Country Status (10)

Country Link
EP (1) EP2271644A1 (en)
JP (1) JP2011516453A (en)
KR (1) KR20110002459A (en)
CN (1) CN101970431A (en)
AU (1) AU2009232012A1 (en)
BR (1) BRPI0910991A2 (en)
CA (1) CA2719070A1 (en)
EA (1) EA201001517A1 (en)
MX (1) MX2010010876A (en)
WO (1) WO2009121914A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057160A2 (en) * 2009-11-06 2011-05-12 The Regents Of The Uiversity Of California Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
CN102638981B (en) 2009-10-14 2015-07-22 默沙东公司 Substituted piperidines that increase p53 activity and the uses thereof
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds
US8987274B2 (en) 2011-10-28 2015-03-24 Merck Sharp & Dohme Corp Macrocycles that increase p53 activity and the uses thereof
TW201429969A (en) 2012-12-20 2014-08-01 Merck Sharp & Dohme Substituted imidazopyridines as HDM2 inhibitors
CN105001300A (en) * 2014-04-17 2015-10-28 复旦大学 Cathepsin D inhibitor, preparation method, pharmaceutical composition and applications thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
EP1911758A1 (en) * 2006-10-04 2008-04-16 Speedel Experimenta AG Phenyl piperidine derivatives for use as renin inhibitors
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds

Also Published As

Publication number Publication date
EA201001517A1 (en) 2011-04-29
AU2009232012A1 (en) 2009-10-08
CN101970431A (en) 2011-02-09
KR20110002459A (en) 2011-01-07
EP2271644A1 (en) 2011-01-12
CA2719070A1 (en) 2009-10-08
MX2010010876A (en) 2010-10-26
WO2009121914A1 (en) 2009-10-08
JP2011516453A (en) 2011-05-26

Similar Documents

Publication Publication Date Title
BRPI0922845A2 (en) pyrazol-4-n-alkoxycarboxamides as microbiocides
SMT201600045B (en) C7-FLUORO REPLACED TETRACYCLINIC COMPOUNDS
DK2288375T3 (en) PEGYLED INSULIN-LISPRO COMPOUNDS
BRPI0920707A2 (en) compounds
CR10926A (en) NEW 2-AMINOOXAZOLINAS AS LIGANDOS TAAR1
DK2242759T3 (en) compounds
BRPI0913879A2 (en) phenylpyrazinones as kinase inhibitors
BRPI0913931A2 (en) modified polyolefins
BRPI0916218A2 (en) heterocyclic compounds as pesticides compositions
BRPI1012247A2 (en) insecticide compounds
DK2340021T3 (en) SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDES
BRPI0916931A2 (en) therapeutic agents
BRPI1015931A2 (en) Insecticide Compounds
BRPI0911347A2 (en) gamma-substituted lactams as therapeutic agents
DK2326651T3 (en) BUPRENORPHIN ANALOGS
BRPI0912475A2 (en) compounds as kinase inhibitors
DK2297162T3 (en) compounds
DK3300729T3 (en) THERAPEUTIC COMPOSITIONS CONTAINING MACITENTAN
BRPI1013941A2 (en) insecticide compounds
BR112012002336A2 (en) azaheterocyclic compounds
BRPI0916432A2 (en) compounds
BRPI1012055A2 (en) "substituted piperidines"
BRPI0910991A2 (en) Substituted piperidines as therapeutic compounds
BRPI1007410A2 (en) aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
BRPI0910931A2 (en) therapeutic substituted cyclopentanes

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired